Skip to main content
. 2024 Oct 28;8:e57376. doi: 10.2196/57376

Table 1.

Baseline demographics; participants in this remote, exploratory cohort study were adults in the United States who vaped nicotine daily (N=73).

Characteristic Values
Demographics

Age (y), mean (SD) 37.4 (11.3)

Gender, n (%)


Women 38 (52)


Men 33 (45)


Prefer to self-describe 2 (3)

Race, n (%)


American Indian or Alaska native 1 (1)


Asian 3 (4)


Black or African American 4 (5)


Hispanic, Latino or Latina, or Spanish origin 4 (5)


Native Hawaiian or other Pacific Islander 1 (1)


White 58 (79)


Some other race 2 (3)

Ethnicity, n (%)


Hispanic, Latino or Latina, or Spanish origin 8 (11)


Not of Hispanic, Latino or Latina, or Spanish origin 65 (89)

Educational level, n (%)


High school or GEDa 4 (5)


Some college 22 (30)


Associate (2-y) degree 9 (12)


Bachelor’s (4-y) degree 26 (36)


Master’s degree 10 (14)


Professional or doctorate degree 2 (3)

Income (US $), n (%)


<25,000 8 (11)


25,000-34,999 3 (4)


35,000-49,999 10 (14)


50,000-74,999 12 (16)


75,000-99,999 14 (19)


100,000-149,999 15 (21)


≥150,000 11 (15)

Employment, n (%)


Yes, ≥20 h/wk 54 (74)


Yes, <20 h/wk 7 (10)


No 12 (16)

Smartphone, n (%)


iPhone 43 (59)


Android 30 (41)
Vaping and quitting behavior

Vape sessions per dayb, mean (SD) 14.6 (6)

Years vaping, mean (SD) 3.5 (3)

Age when they first started thinking of themselves as someone who vapes (y), mean (SD) 33.9 (12)

Vape device used, n (%)


Refillable 20 (27)


Prefilled or disposable (single use) 44 (60)


Both 9 (12)

Uses vape or e-cigarette flavors, n (%) 59 (81)

First vape session after waking, n (%)


Within 5 min 40 (55)


6-15 min 18 (25)


16-30 min 9 (12)


31-60 min 3 (4)


61-120 min 2 (3)


After 120 min 1 (1)

Vaping dependence via the PSECDI c , n (%)


Low dependence 3 (4)


Medium dependence 20 (27)


High dependence 50 (68)

Quit attempts in the previous 12 months, mean (SD) 1.7 (2.0)

Attitudes toward quitting vaping, mean (SD)


DTQd 4.0 (2.8)


STQe 4.9 (2.9)

Alcohol use behavior via the AUDIT-Cf, mean (SD) 2.3 (2.3)

Presence of depressive symptoms via the CES-Dg, mean (SD) 9.8 (6.4)
Current product and medication use, n (%)

Tobacco products used


e-Cigarettes or vaping only 72 (99)


e-Cigarettes or vaping+hookah 1 (1)

Other vape juice or e-liquid products used h


None 60 (82)


CBDi 5 (7)


THCj 11 (15)


Other 1 (1)

Medications currently taking


None 67 (92)


Bupropion (Zyban/Wellbutrin) 4 (5)


NRTk—gum 1 (1)


NRT—patch 1 (1)
Former smoking-related measures

Former smokers, n (%) 53 (73)

Years smoked, mean (SD) 13.2 (10.3)

Started vaping to quit smoking, n (%) 43 (59)

Continued vaping to quit smoking or stay quit, n (%) 30 (41)

aGED: General Educational Development.

bParticipants were provided with a drop-down menu for vape sessions per day with a selection from 0 to >20; >20 was converted to 21.

cPSECDI: Penn State Electronic Cigarette Dependence Index; 10 items (where a score of 0-3 indicates no dependence, a score of 4-8 indicates low independence, a score of 9-12 indicates medium dependence, and a score of ≥13 indicates high dependence).

dDTQ: difficulty staying quit; “If you were to quit vaping/e-cigs right now, how difficult do you think it would be to stay vape free? (1=Really difficult to stay vape/e-cig free; 10=Really easy to stay vape/e-cig).”

eSTQ: success in quitting; “If you were to quit vaping/e-cigs right now, how successful would you be? (1=not at all successful; 10=completely successful).”

fAUDIT-C: Alcohol Use Disorders Identification Test–Concise screening questionnaire; 3 items (where a score of 0 indicates no alcohol use and a score of ≥4 among men and ≥3 among women is considered positive for alcohol use disorder).

gCES-D: Center for Epidemiologic Studies Depression Scale; 10 items (where a higher score indicates greater symptoms of depression; a cutoff score of ≥10 indicates the presence of significant depressive symptoms).

hParticipants were asked to select all that applied.

iCBD: cannabidiol.

jTHC: tetrahydrocannabinol.

kNRT: nicotine replacement therapy.